Source author record

Amit M. Joshi

Amit M. Joshi appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
3close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Dielectric-Modulated Double Gate Bilayer Electrode Organic Thin Film Transistor-based Biosensor for Label-Free Detection: Simulation Study and Sensitivity Analysis

A dielectric-modulated double gate bilayer electrodes organic thin-film transistor (DMDGBE-OTFT) based sensor is proposed for label-free biomolecule detection. The double gate of DMDGBE-OTFT is used for creating two symmetrical gates underlap regions on both sides of the organic semiconductor. The parallel immobilization of biomolecule in two gates underlaps region changes the on-current (ION) of the DMDGBEOTFT. Bilayer electrode is also used for significant reduction of barrier height to enhance the performance of the proposed device. The change in the drain current has been utilized to evaluate the sensitivity of the DMDGBE-OTFT for biomolecule recognition having different dielectric constants and corresponding charge densities using 2-D physics-based numerical simulation when biomolecules are immobilized in the gate underlap area. The ATLAS TCAD tool is used to investigate the sensitivity performance of the DMDGBE-OTFT. The proposed DMDGBE-OTFT has 24.2% higher sensitivity in comparison to the recently reported OTFT-based biosensors for label-free detection of biomolecules. The DMDGBE-OTFT biosensor has a lot of potential for flexible biosensing applications in the future because of its flexibility, high sensitivity, biocompatibility and low cost.

preprint2020arXiv

Smart Healthcare for Diabetes: A COVID-19 Perspective

Diabetes is considered as an critical comorbidity linked with the latest coronavirus disease 2019 (COVID-19) which spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). The diabetic patients have higher threat of infection from novel corona virus. Depending on the region in the globe, 20% to 50% of patients infected with COVID-19 pandemic had diabetes. The current article discussed the risk associated with diabetic patients and also recommendation for controlling diabetes during this pandemic situation. The article also discusses the case study of COVID-19 at various regions around the globe and the preventive actions taken by various countries to control the effect from the virus. The article presents several smart healthcare solutions for the diabetes patients to have glucose insulin control for the protection against COVID-19.